Tepezza Hearing Loss Lawsuit: Has the Quest for Justice Ended?
Tepezza, or Teprotumumab, is a drug produced by Horizon Therapeutics as a treatment option for thyroid eye disease (TED). This autoimmune condition is considered to be debilitating, affecting the fatty tissues and muscles behind the patient’s eye. Tepezza emerged as a breakthrough in TED treatment, receiving its Food and Drug Administration (FDA) approval in January…
